Literature DB >> 7697840

Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina.

D L Brown1, M S Hibbs, M Kearney, C Loushin, J M Isner.   

Abstract

BACKGROUND: Acute coronary ischemia is usually initiated by rupture of atherosclerotic plaque, leading to intracoronary thrombosis and clinical sequelae. The proximate cause of plaque rupture is unknown. Accordingly, we investigated the potential role of the 92-kD gelatinase member of the matrix metalloproteinase family in acute coronary ischemia. METHODS AND
RESULTS: Coronary atherectomy specimens from patients with atherosclerosis and an acute ischemic syndrome consistent with recent plaque rupture (unstable angina) (n = 12) were immunostained for the presence of 92-kD gelatinase; the results were compared with those obtained by identical study of atherectomy specimens from patients with atherosclerosis and angina but without acute ischemia (stable angina) (n = 12). Positive immunostaining for 92-kD gelatinase was present in 83% of specimens from both unstable and stable angina patients. However, intracellular localization of enzyme (indicating active synthesis) was documented in 10 of 10 positively stained specimens from patients with unstable angina compared with 3 of 10 positively stained specimens from patients with stable angina. Macrophages and smooth muscle cells were the major sources of 92-kD gelatinase in all specimens examined by immunostaining of adjacent sections.
CONCLUSIONS: 92-kD gelatinase is commonly expressed in coronary arterial atherosclerotic lesions. Active synthesis of 92-kD gelatinase by macrophages and smooth muscle cells in atherosclerotic lesions may play a pathogenic role in the development of acute coronary ischemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697840     DOI: 10.1161/01.cir.91.8.2125

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  79 in total

1.  Intravascular radiotherapy: restenosis and more?

Authors:  P Wexberg; M Gottsauner-Wolf
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 2.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Authors:  D Praticò; L Iuliano; A Mauriello; L Spagnoli; J A Lawson; J Rokach; J Maclouf; F Violi; G A FitzGerald
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

4.  Morphologic Features of Carotid Plaque Rupture Assessed by Optical Coherence Tomography.

Authors:  S Shindo; K Fujii; M Shirakawa; K Uchida; Y Enomoto; T Iwama; M Kawasaki; Y Ando; S Yoshimura
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

5.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.

Authors:  Peter J Gough; Ivan G Gomez; Paul T Wille; Elaine W Raines
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

6.  Study of Serum CD147 Level in Patients with Transient Ischemic Attack and CD147 Expression in Atherosclerotic Plaque.

Authors:  Bin Xu; Chan Wu; Wenqing Wu; Yanguo Tan; Nannan Sun; Jian Cui; Siyu Lu; Jing Wang; Shan Cen
Journal:  J Cardiovasc Transl Res       Date:  2018-07-23       Impact factor: 4.132

Review 7.  Metalloproteinases and plasminogen activators in vessel remodeling.

Authors:  Alex Bobik; Vselovod Tkachuk
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

8.  Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.

Authors:  Takayuki Fujiwara; Toshiro Matsunaga; Kunihiko Kameda; Naoki Abe; Hirotsugu Ono; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

9.  Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.

Authors:  Young Mi Hong; Hyun-Seung Jin; In Sook Park; Soo-Jong Hong
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

10.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

Authors:  B Cowan; O Baron; J Crack; C Coulber; G J Wilson; M Rabinovitch
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.